胃癌辅助化疗临床试验解读.ppt

胃癌辅助化疗临床试验解读.ppt

ID:61896645

大小:866.01 KB

页数:35页

时间:2021-03-26

胃癌辅助化疗临床试验解读.ppt_第1页
胃癌辅助化疗临床试验解读.ppt_第2页
胃癌辅助化疗临床试验解读.ppt_第3页
胃癌辅助化疗临床试验解读.ppt_第4页
胃癌辅助化疗临床试验解读.ppt_第5页
资源描述:

《胃癌辅助化疗临床试验解读.ppt》由会员上传分享,免费在线阅读,更多相关内容在教育资源-天天文库

1、AdjuvantChemotherapyforGastricCancer withS-1,anOralFluoropyrimidine--ACTS-GCIntroductionMeta-analyseshaveshownthatadjuvantchemotherapyiseffectiveintreatinggastriccancer.However,theeffectivenessofspecificregimenshasnotbeenverifiedinlargeclinicaltrials.BackgroundAdvancedgastriccancercanres

2、pondtoS-1,anoralfluoropyrimidine.WetestedS-1asadjuvantchemotherapyinpatientswithcurativelyresectedgastriccancer.METHODSPatientsinJapanwithstageIIorIIIgastriccancerwhounderwentgastrectomywithextended(D2)lymph-nodedissectionwererandomlyassignedtoundergosurgeryfollowedbyadjuvanttherapywithS

3、-1ortoundergosurgeryonly.METHODSIntheS-1group,administrationofS-1wasstartedwithin6weeksaftersurgeryandcontinuedfor1year.Thetreatmentregimenconsistedof6-weekcyclesinwhich,inprinciple,80mgoforalS-1persquaremeterofbody-surfaceareaperdaywasgivenfor4weeksandnochemotherapywasgivenforthefollowi

4、ng2weeks.Theprimaryendpointwasoverallsurvival.EligibilityCriteriaThecriteriaforeligibilitywerehistologicallyprovengastriccancerofstageII,IIIA,orIIIB;D2ormoreextensivelymph-nodedissectionwithR0surgery;nohepatic,peritoneal,ordistantmetastasis;notumorcellsinperitonealfluidoncytologicanalysi

5、s;anageof20to80years;noprevioustreatmentforcancerexceptfortheinitialgastricresectionfortheprimarylesion;andadequateorganfunction.StudyDesignandTreatmentTheprimaryendpointwasoverallsurvival;secondaryendpointswererelapse-freesurvivalandthedegreeofsafetyofS-1.Patientswereenrolled,within6wee

6、ksaftersurgeryandrandomlyassignedtoeithertheS-1grouporthesurgery-onlygroup.StudyDesignandTreatmentPatientsassignedtotheS-1groupreceivedtwooraldosesof40mgofS-1persquaremeterofbody-surfaceareaperday,for4weeks,followedby2weeksofnochemotherapy.This6-weekcyclewasrepeatedduringthefirstyearafte

7、rsurgery.Thesurgery-onlygroupreceivednoanticancertreatmentaftersurgery,unlesstherewasaconfirmedrelapse.Patientsinbothgroupsweretobefollowedupfor5yearspostoperatively.RESULTSWerandomlyassigned529patientstotheS-1groupand530patientstothesurgeryonlygroupbetweenOctober2001andD

当前文档最多预览五页,下载文档查看全文

此文档下载收益归作者所有

当前文档最多预览五页,下载文档查看全文
温馨提示:
1. 部分包含数学公式或PPT动画的文件,查看预览时可能会显示错乱或异常,文件下载后无此问题,请放心下载。
2. 本文档由用户上传,版权归属用户,天天文库负责整理代发布。如果您对本文档版权有争议请及时联系客服。
3. 下载前请仔细阅读文档内容,确认文档内容符合您的需求后进行下载,若出现内容与标题不符可向本站投诉处理。
4. 下载文档时可能由于网络波动等原因无法下载或下载错误,付费完成后未能成功下载的用户请联系客服处理。